|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
845.91 Million
|
|
Market
Size (2030)
|
USD
1366.46 Million
|
|
CAGR
(2025-2030)
|
8.28%
|
|
Fastest
Growing Segment
|
Ultrasound
System
|
|
Largest
Market
|
West
India
|
Market Overview
India
Diagnostic Imaging Market was valued at USD 845.91 Million in 2024 and is expected to reach USD 1366.46 Million by 2030 with a CAGR of 8.28% during the forecast period.
Diagnostic imaging involves non-invasive techniques used to detect, monitor, and evaluate diseases or injuries by generating detailed images of the body. These methods help healthcare professionals accurately assess patient conditions and plan appropriate treatments.
Common technologies include X-ray for imaging bones and tissues, MRI for detailed visualization of internal structures, CT scans for cross-sectional imaging, and ultrasound for real-time imaging of organs. Nuclear imaging techniques such as PET scans further enable the analysis of metabolic activity. These advanced imaging modalities enhance diagnostic accuracy, support personalized treatment planning, and improve patient outcomes.
Download Free Sample Report
Key Market Drivers
Rise
in the Prevalence of Chronic Diseases and Increased Adoption of Advanced Technologies in Medical Imaging
India’s diagnostic imaging demand is rising because the country is carrying a much heavier chronic disease burden than it did a generation ago, and this directly increases the need for timely CT, MRI, PET, ultrasound, and digital X-ray examinations across oncology, cardiology, pulmonology, endocrinology, and musculoskeletal care.
The Government of India has stated that the share of deaths caused by non communicable diseases rose from 37.9 percent in 1990 to 61.8 percent in 2016, while the national response has expanded to include 677 district level NCD clinics, 187 district cardiac care units, 266 district day care centres, and 5,392 NCD clinics at community health centre level, showing how disease pressure is already reshaping diagnostic infrastructure. This burden is intensifying because cancer, diabetes, heart disease, chronic respiratory disease, and age related bone disorders all require repeated imaging for screening, diagnosis, treatment planning, and follow up, and higher awareness among patients is pushing hospitals to invest in better image quality and quicker turnaround times.
For instance, Siemens Healthineers said its India operations now include more than 3,900 employees and local manufacturing for both CT and MRI in Bengaluru under the government’s PLI framework, which is a strong signal that major imaging companies see sustained and widening demand from India’s chronic care pathway rather than only from premium urban hospitals.
Increased
Adoption of Advanced Technologies in Medical Imaging
India’s diagnostic imaging ecosystem is moving beyond basic scan availability and toward more sophisticated systems that improve speed, consistency, image quality, and workflow efficiency, which is why technologies such as digital radiography, multi-slice CT, helium-free MRI platforms, AI-enabled reconstruction, and portable ultrasound are gaining stronger acceptance across hospitals and diagnostic chains.
This shift matters because advanced platforms help clinicians detect disease earlier, assess organ function more clearly, reduce repeat scans, and manage larger patient volumes without compromising diagnostic confidence, which is especially important in a market where specialist radiology capacity is still unevenly distributed across metro and non-metro centres. Government-backed manufacturing policies are also helping accelerate this transition, since local production lowers dependence on imports, supports faster deployment, and encourages vendors to design equipment for Indian clinical settings, including facilities with space, cost, and infrastructure constraints. Major manufacturers are now aligning their India strategy with these needs by localizing production and introducing platforms that emphasize operational productivity as much as clinical performance, making advanced imaging more practical for second-tier and third-tier cities.
For instance, Wipro GE Healthcare said its Made in India Revolution Aspire CT, produced at its domestic plant backed by an investment of a little over Rs 100 crore, can deliver up to 50 percent higher patient throughput, underscoring how technology adoption in India is increasingly tied to scale, workflow efficiency, and wider geographic access rather than only to premium innovation.
Growing
Geriatric Population
India’s aging population is becoming a major structural driver for diagnostic imaging because older adults face a much higher risk of hypertension, diabetes, stroke, chronic lung disease, arthritis, osteoporosis, dementia, and cancer, all of which require imaging not just for first diagnosis but also for long term monitoring and treatment decisions. Government data shows that the population aged 60 years and above is projected to rise from 100 million in 2011 to 230 million by 2036, which means nearly one in seven Indians will be an older adult, and that demographic transition will steadily increase demand for chest imaging, brain scans, vascular imaging, oncology screening, and musculoskeletal assessments.
This is especially relevant for India because elderly patients often need repeat and lower stress imaging pathways, so hospitals are under pressure to adopt systems that are easier to install, more efficient to run, and better suited for continuous service delivery across both large cities and emerging regional care centres. Better healthcare awareness and expanding public and private investment are also improving the likelihood that seniors seek diagnostic care earlier, which can reduce complications and support more effective disease management over time.
For instance, Philips announced in India that it had already achieved more than 1,500 installations worldwide of its helium-free 1.5T wide-bore MRI platform and launched its AI-enabled CT 5300 for the Indian market, illustrating how major imaging companies are positioning elder-friendly, workflow-oriented technologies for a country where the senior population is set to expand sharply.
Rising
Demand for The Early Detection of Diseases
The push for early disease detection is becoming one of the clearest growth drivers for imaging in India because doctors and health systems increasingly recognize that earlier identification of cancer, diabetes linked complications, cardiovascular conditions, respiratory disorders, fractures, and abdominal disease can sharply improve treatment planning and reduce downstream clinical burden.
India’s policy framework is also moving in this direction, as the government has rolled out a population-based initiative for prevention, control, and screening of common NCDs and specifically targets people above 30 years of age for screening under Ayushman Bharat Health and Wellness Centres, which expands the funnel of patients who may require confirmatory or follow up imaging after initial risk assessment.
This makes CT, MRI, ultrasound, and digital X ray increasingly central to preventive care because clinicians need fast, reliable, and scalable tools to investigate suspicious symptoms before disease progresses to a more expensive or less treatable stage. Rising health awareness, broader diagnostic expectations, and stronger public-private participation are reinforcing this shift, particularly as India tries to narrow the urban-rural gap in access to quality diagnostics without sacrificing productivity or scan quality.
For instance, Siemens Healthineers said its MAGNETOM Free. Star is now manufactured in Bengaluru and designed as a virtually helium free MRI with an ultra compact footprint that is easier to install, a useful example of how companies are tailoring advanced imaging platforms to support earlier diagnosis in Indian facilities that need both clinical sophistication and practical deployment flexibility.
Key Market
Challenges
High
Cost of Diagnostic Imaging Procedures and Equipment
The
high cost of diagnostic imaging procedures and equipment is significantly
affecting the overall demand for these critical services. Diagnostic imaging,
encompassing essential techniques such as MRI, CT scan, and X-ray, plays a
crucial role in ensuring accurate diagnosis and effective treatment. However,
the exorbitant costs associated with these advanced technologies pose a
significant barrier, limiting access for the average Indian.
Moreover,
the financial burden extends to the establishment of diagnostic imaging centers
equipped with state-of-the-art equipment. The substantial investment required
in setting up these facilities leads to increased pricing for procedures,
further exacerbating the affordability challenge. Consequently, numerous
patients are compelled to defer or completely forgo necessary diagnostic
procedures, resulting in a restricted demand.
Furthermore,
the disparity in the distribution of these facilities, primarily concentrated
in urban areas, exacerbates the accessibility and demand gap in rural regions.
As a consequence, individuals residing in remote areas face additional hurdles
in obtaining vital diagnostic services, further widening the healthcare divide.
Recognizing the urgency of addressing this issue, the Indian government has
initiated efforts to alleviate the situation through public-private
partnerships, subsidies, and initiatives like the Ayushman Bharat Yojana.
However, it is evident that there remains a long road ahead in making
diagnostic imaging more affordable and accessible to all segments of society,
thereby increasing the overall demand and improving healthcare outcomes.
Side
Effects of Diagnostic Imaging Procedures
Diagnostic
imaging procedures, such as computed tomography (CT) scans and X-rays, have
become increasingly valuable in modern healthcare. They play a crucial role in
diagnosing and monitoring various medical conditions, allowing healthcare
professionals to make informed decisions about patient care. However, in India,
the demand for these procedures is currently experiencing a downturn due to
concerns about the potential side effects associated with radiation exposure.
Radiation
exposure from CT scans and X-rays can have varying side effects, ranging from
minor issues like temporary skin reddening to more significant risks like
radiation-induced cancer. These risks, although relatively low, have raised
concerns among patients and healthcare providers alike. Additionally, the
invasive nature of certain imaging procedures can cause anxiety and stress for
patients, further contributing to the hesitancy in seeking such diagnostic
tests. Another factor that contributes to the decreased demand for diagnostic
imaging procedures in India is the high cost involved. These imaging tests are
often not covered by health insurance, making them inaccessible for many
individuals. The financial burden associated with these procedures acts as a
significant barrier, deterring patients from undergoing such tests unless
absolutely necessary.
The
cumulative effect of these factors has led to a decreased demand for diagnostic
imaging procedures in India. Patients and healthcare providers are actively
seeking safer, less invasive, and cost-effective alternatives to address their
diagnostic needs. This shift in demand highlights the importance of exploring
and adopting innovative technologies and practices that can provide accurate
diagnoses while minimizing potential risks and costs.
Key Market Trends
Growing
Expenditure in The Healthcare Sector
India’s healthcare spending is rising in a way that is directly strengthening demand for diagnostic imaging, because higher public funding, wider insurance coverage, stronger hospital networks, and more investment in research and digital systems all improve the country’s ability to buy, install, and use advanced CT, MRI, ultrasound, and PET based platforms for earlier and more accurate diagnosis.
The latest parliamentary and budget disclosures show that government health expenditure reached Rs 4,34,163 crore in 2021 to 2022, while the Union Budget for 2026 to 2027 allocated Rs 1,06,530.42 crore to the Ministry of Health and Family Welfare, with Rs 4,770 crore earmarked for the Ayushman Bharat Health Infrastructure Mission, Rs 11,307 crore for PMSSY including new AIIMS, and Rs 4,000 crore for ICMR, indicating that the healthcare system is being funded not only for treatment delivery but also for diagnostics, hospital modernization, and research capacity.
This matters for imaging because India’s growing burden of cancer, cardiovascular disease, diabetes, respiratory conditions, and age related disorders requires repeated scans for screening, staging, treatment planning, and follow up, which naturally pushes hospitals and diagnostic centres to expand machine availability and upgrade image quality.
For instance, Siemens Healthineers said it would invest Rs 1,300 crore in India over five years to build an innovation hub combining R and D and medical imaging manufacturing, showing that large private players are scaling capacity in step with India’s rising healthcare expenditure and long term diagnostic demand.
Increasing
Adoption of Latest Technologies in Diagnostic Imaging Equipment
India is also witnessing stronger adoption of advanced diagnostic imaging technologies as providers move beyond basic scan capacity and focus on faster throughput, sharper image reconstruction, lower radiation exposure, and better workflow efficiency, all of which are essential in a market facing high patient volumes, uneven specialist availability, and a growing need for early diagnosis.
Hospitals and diagnostic centres are increasingly leaning toward systems such as AI enabled CT, high definition MRI, digital radiography, and more capable ultrasound platforms because these technologies allow clinicians to detect disease with greater precision while also improving operational performance in busy settings across metro and non metro India. The push is further supported by local manufacturing and policy backing, since India is trying to reduce dependence on imported high end medical devices and extend quality diagnostics into tier 2 and tier 3 cities where access gaps have historically been wide.
Segmental Insights
Type Insights
Based on the
type, in 2024, The ultrasound systems segment has emerged as the largest market share holder within the medical imaging industry, a position driven by the growing adoption of ultrasound equipment in the healthcare sector. The segment’s dominance can be attributed to the affordability, advanced features, and user-friendly nature of ultrasound technology. Its ability to deliver instant and precise results, coupled with safety advantages such as radiation-free imaging and non-invasive procedures, has made ultrasound one of the most widely utilized diagnostic tools in India. These factors have firmly established ultrasound as a leading segment in the medical imaging market.
Application Insights
Based on the
application, the oncology segment dominated the global diagnostic imaging
market in 2024, in terms of revenue, and is projected to sustain its dominance
during the forecast period. This can be attributed to the increased prevalence
of cancer among the population, particularly with lung cancer being the most
prominent type and accounting for the highest number of cancer deaths in India.
Remarkably, according to the International Agency for Research on Cancer,
breast cancer has now surpassed lung cancer as the most diagnosed type of
cancer. As a result, the demand for oncology diagnostic imaging has experienced
a significant surge, contributing to the growth of this segment.
Download Free Sample Report
Regional Insights
The western region of India, especially Maharashtra, is a key leader in the country’s diagnostic imaging market. Its growth is fueled by advanced healthcare infrastructure, including state-of-the-art hospitals and cutting-edge medical facilities equipped with the latest imaging technologies, enabling precise and efficient diagnoses.
High health awareness among the population drives strong demand for diagnostic imaging services, which is met by major providers and manufacturers with a broad range of solutions tailored to local needs.
Maharashtra’s continuous focus on innovation, technological adoption, and healthcare excellence positions it to maintain its dominance in India’s diagnostic imaging market and act as a catalyst for further industry growth.
Recent Developments
- In February 2026, FUJIFILM India unveiled four new diagnostic imaging and healthcare IT solutions at IRIA 2026, including the FCT iStream CT platform, AMULET SOPHINITY digital mammography, FDR Smart X Essential digital radiography, and the HCIT Fenix ecosystem. The company said these launches were designed to help radiology departments handle rising imaging volumes, workforce constraints, and growing diagnostic complexity, making the rollout one of the clearest recent product expansions in India’s imaging market.
- In October 2025, Philips expanded its collaboration with Nicolab to advance stroke care in India by combining Philips’ imaging systems with Nicolab’s StrokeViewer AI platform. The partnership was framed as a way to improve stroke diagnosis and treatment workflows in India by linking real-time high-resolution imaging with AI-assisted interpretation for faster clinical decision-making.
- In July 2025, Mahajan Imaging & Labs launched India’s first AI-powered ultra-fast MRI at its new Dwarka centre in Delhi through the debut of the Excel 3T MRI scanner. The company said the scanner delivered up to 50% better signal-to-noise ratio and could shorten complex cardiac MRI scan times to about 30-40 minutes, while the centre also added AI-enabled ultrasound, cardiac CT, mammography, digital X-ray, and bone densitometry as part of a broader integrated imaging ecosystem.
- In March 2025, India’s first indigenous MRI machine was reported as having been developed and scheduled for installation at AIIMS Delhi for trials, marking a major domestic breakthrough in high-end diagnostic imaging technology. The development was positioned as an important step toward reducing dependence on imported MRI systems while strengthening local innovation capacity in advanced radiology equipment.
Key Market Players
- Wipro GE Healthcare Private Limited
- Siemens Healthineers India
- Allengers Medical Systems Limited
- Erbis Engineering Co Limited
- Samsung India Electronics (SIEL)
- Philips India Limited
- Olympus Medical Systems India Private
Limited
- Fujifilm India Private Limited
- Carestream Health India Private Limited
- Shimadzu Medicals (India) Private
Limited
|
By Type
|
By Mobility
|
By Source
|
By Application
|
By Component
|
By End User
|
By Region
|
|
- X-Ray Imaging Solutions
- Ultrasound Systems
- MRI Systems
- CT Scanner
- Nuclear Imaging Solutions
- Mammography
- Others
|
|
|
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Others
|
|
- Hospitals & Clinics
- Diagnostic Centers
- Ambulatory Care Centers
- Others
|
- North India
- South India
- West India
- East India
|
|
|
|
|
|
|
|
|
Report
Scope:
In
this report, the India Diagnostic Imaging Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- India Diagnostic Imaging Market, By Type:
o
X-Ray Imaging Solutions
o
Ultrasound Systems
o
MRI Systems
o
CT Scanner
o
Nuclear Imaging Solutions
o
Mammography
o
Others
- India Diagnostic Imaging Market, By Mobility:
o
Portable
o
Standalone
- India Diagnostic Imaging Market, By Source:
o
Domestic
o
Import
- India Diagnostic Imaging Market, By Application:
o
Cardiology
o
Oncology
o
Neurology
o
Orthopedics
o
Gastroenterology
o
Gynecology
o
Others
- India Diagnostic Imaging Market, By Component:
o
OEM
o
Refurbished
- India Diagnostic Imaging Market, By End User:
o
Hospitals & Clinics
o
Diagnostic Centers
o
Ambulatory Care Centers
o
Others
- India Diagnostic Imaging Market, By Region:
o
North India
o
South India
o
West India
o
East India
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies present in the India Diagnostic Imaging Market.
Available
Customizations:
India
Diagnostic Imaging Market report with the given market data, TechSci
Research offers customizations according to a company's specific needs. The
following customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
India Diagnostic
Imaging Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]